Compare INGN & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INGN | NHS |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.8M | 217.9M |
| IPO Year | 2014 | N/A |
| Metric | INGN | NHS |
|---|---|---|
| Price | $7.20 | $7.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 156.7K | 111.8K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $347,028,000.00 | N/A |
| Revenue This Year | $8.04 | N/A |
| Revenue Next Year | $8.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.68 | N/A |
| 52 Week Low | $5.70 | $6.95 |
| 52 Week High | $12.91 | $9.17 |
| Indicator | INGN | NHS |
|---|---|---|
| Relative Strength Index (RSI) | 59.28 | 58.63 |
| Support Level | $6.53 | $7.15 |
| Resistance Level | $7.46 | $7.49 |
| Average True Range (ATR) | 0.18 | 0.09 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 72.04 | 80.68 |
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.